Michael J. Schell
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 71
- Colorectal Cancer Treatments and Studies 16
- Cancer Immunotherapy and Biomarkers 13
- Lung Cancer Research Studies 10
-
- Lung Cancer Treatments and Mutations 22
- Co-authors
- Gerold Bepler (19 shared papers)Mark A. Socinski (12 shared papers)Tawee Tanvetyanon (13 shared papers)Lennie Lott (1 shared paper)Gaston K. Rivera (1 shared paper)Walter T. Hughes (1 shared paper)Richard D. Kim (10 shared papers)Eric B. Haura (15 shared papers)
- Journals
- Journal of Clinical Oncology (23 papers)Cancer (11 papers)Cancer Research (6 papers)Clinical Cancer Research (6 papers)Oncotarget (5 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Michael J. Schell
166 papers receiving 6.5k citations
Michael J. Schell's Hit Papers
Peers
Comparison fields: 5 of 155
- Oncology 2.6k
- Pulmonary and Respiratory Medicine 1.5k
- Cancer Research 551
- Pathology and Forensic Medicine 508
- Immunology 498
Countries citing papers authored by Michael J. Schell
This map shows the geographic impact of Michael J. Schell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Schell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Schell more than expected).
Fields of papers citing papers by Michael J. Schell
This network shows the impact of papers produced by Michael J. Schell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Schell. The network helps show where Michael J. Schell may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael J. Schell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 177 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer Hit paper breakdown → | 2020 | 320 |
| 2 | 1987 | 316 | |
| 3 | 2008 | 256 | |
| 4 | 2001 | 230 | |
| 5 | 2014 | 216 | |
| 6 | 2016 | 207 | |
| 7 | 1995 | 166 | |
| 8 | 2002 | 163 | |
| 9 | 2006 | 161 | |
| 10 | 2010 | 158 | |
| 11 | 2016 | 157 | |
| 12 | 2016 | 147 | |
| 13 | 2009 | 142 | |
| 14 | 2001 | 140 | |
| 15 | 2012 | 127 | |
| 16 | 2013 | 116 | |
| 17 | 2019 | 115 | |
| 18 | 2003 | 109 | |
| 19 | 2014 | 103 | |
| 20 | 2002 | 94 |
About Michael J. Schell
Michael J. Schell is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Epidemiology, having authored 177 papers that have together received 6.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (22 papers), Colorectal Cancer Treatments and Studies (16 papers), Cancer Immunotherapy and Biomarkers (13 papers), Cancer Genomics and Diagnostics (11 papers), Lung Cancer Research Studies (10 papers), Head and Neck Cancer Studies (9 papers), Statistical Methods in Clinical Trials (9 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Oncology (2.6k citations), Pulmonary and Respiratory Medicine (1.5k citations), Cancer Research (551 citations), Pathology and Forensic Medicine (508 citations) and Immunology (498 citations). Michael J. Schell has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Gerold Bepler, Mark A. Socinski, Tawee Tanvetyanon, Lennie Lott, Gaston K. Rivera, Walter T. Hughes, Richard D. Kim, Eric B. Haura, Ji‐Hyun Lee and Alberto Chiappori. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Cancer Research, Clinical Cancer Research and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.